Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Preparation and identification of monoclonal antibodies against the extracellular domain of integrin α6 subunit-the specific laminin receptor

Microsoft Word-Yuan et al PDF

Preparation and Application of Monoclonal Antibody Against Hndrg2

Preparation and characterization of a novel monoclonal antibody against human PD-1

Production and Application of Monoclonal Antibodies to GST

Preparation and Identification of Monoclonal Antibody Against Human Testis Development Related Gene 1

[Preparation of Monoclonal Antibodies Against Human Mesenchymal Stem Cells].

Study on the monoclonal antibody to chlorpyrifos.

Preparation and Identification of a Polyclonal Antibody Targeting at CD151/Integrin α6β1 Binding Domain

[Laminin and Its Alpha 6 Integrin Receptor in the Regulation of Human Hepatocellular Carcinoma Cell Phenotypes].

Preparation and Characterization of Monoclonal Antibody Against Human LSECtin

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Preparation and Identification of a Monoclonal Antibody Against GDDR Protein

Production and Identification of Monoclonal Antibodies to Chcd25

Preparation of Monoclonal Antibodies Against Glutathione-S-transferase (GST)

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Preparation and Identification of Monoclonal Antibodies Against Humanin

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Preparation of anti-human esophageal cancer invasion and metastasis functional monoclonal antibody

Preparation and Characterization of Monoclonal Antibody Against Human Angiopoietin-Like Protein 2